The 35 references in paper S. Kozlova N., A. Golubev V., U. Krylova S., K. Syssoev A., E. Shlyakhto V., N. Neznanov G., Areg Totolian A., С. Козлова Н., А. Голубев В., Ю. Крылова C., К. Сысоев А., Е. Шляхто В., Н. Незнанов Г., Арег Тотолян А. (2014) “ВЛИЯНИЕ ЦИТОКИНОВ НА КОМОРБИДНОСТЬ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И АФФЕКТИВНЫХ РАССТРОЙСТВ ТРЕВОЖНО-ДЕПРЕССИВНОГО СПЕКТРА // IMPACT OF CYTOKINES UPON COMORBID STATES OF CORONARY ARTERY DISEASE AND AFFECTIVE DISORDERS ASSOCIATED WITH DEPRESSION AND ANXIETY” / spz:neicon:mimmun:y:2010:i:3:p:235-240

1
Андросова Л.В., Кушнер С.Г., Абрамова Л.И., Олейчик И.В., Егорова М.Ю. Уровень интерлейкинов при эндогенных депрессиях // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2001. – Т. 101. – С. 45-48
(check this in PDF content)
2
Anisman H., Ravindran A.V., Griffiths J., Merali Z. Interleukin-1 beta production in dysthymia before and after pharmacoterapy // Biol. Psychiatr. – 1999. – Vol. 46. – P. 1649-1655.
(check this in PDF content)
3
Barefoot J.C., Helms M.J., Mark D.V. Depression and long-term mortality risk in patients with coronary artery diseas // Am. J. Cardiol. – 1996. – Vol. 78. – P.613-617.
(check this in PDF content)
4
Besedovsky H.O., delRay A., Sorkin A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones // Science. – 1986. – Vol. 233. – P. 652-654.
(check this in PDF content)
5
Connor T.J., Leonard B.E. // Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences. – 1998. – Vol. 62. – P. 583-606.
(check this in PDF content)
6
Coppen A., Wood K. Triptophan and depressive illness // Psychol. Med.. – 1978. – Vol. 8. – P. 49-57.
(check this in PDF content)
7
Coryell W., Noyes R., House J.D. Mortality among outpatients with anxiety disorders // Am. J. Psychiatr. – 1986. – Vol. 14, N 3. – P. 508-510.
(check this in PDF content)
8
Dicknes C., McGowan L., Clark-Carter D. Depression in rheumatoid arthritis, a systematic review of the literature with meta-analysis // Psychosom. Med. – 2002. – Vol. 64. – P. 52-60.
(check this in PDF content)
9
Felger J.C., Alagbe O., Hu F., Mook D., Freeman A.A., Sanchez M.M., Kalin N.H., Ratti E., Nemeroff C.B., Miller A.H. Effects of interferonalpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression // Biol. Psychiatr. – 2007. – Vol. 62. – P. 1324-1333.
(check this in PDF content)
10
Hamilton M. Hamilton anxiety scale // In: Gue W. ed. ECDEU Assessment manual for psycholopharmacology: Rev. Ed. Washington DC: US Department of Health, Education and Welfare. – 1976. – P. 193-198.
(check this in PDF content)
11
Hamilton M. A rating for depression // J. Neurol. Neurosurg. Psychiatr. – 1960. – Vol. 23. – P. 56-61.
(check this in PDF content)
12
Hardardottir I., Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism // Curr. Opin. Lipidol. – 1994. – Vol. 5 – P. 207-215.
(check this in PDF content)
13
Kim J.J., Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories // Nature Reviews Neurocs. – 2002. – Vol. 3. – P. 453-462.
(check this in PDF content)
14
Konsman J.P., Parnet P., Dantzer R. Cytokineinduced sickness behaviour: mechanisms and implications // Trends. Neurosci. – 2002. – Vol. 25. – P. 154-159.
(check this in PDF content)
15
Kronfol Z. Immune dysregulation in major depression: a critical review of exesting evidence // Int. J. Neuropsychopharmacol. – 2002. – Vol. 5. – P. 333-343.
(check this in PDF content)
16
Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain // J. Neurochem. – 1998. – Vol. 70. – P. 452-466.
(check this in PDF content)
17
Licinio J. Central nervous system cytokines and their relevance for neurotoxicity and apoptosis // J. Neural. Transmission (Suppl.). – 1997. – Vol. 49. – P. 169-175.
(check this in PDF content)
18
Licinio J., Wong M.-L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stressresponsive systems and contribute to neurotoxicity and neuroprotection // Mol. Psychiatr. – 1999. – Vol. 4. – P. 317-327.
(check this in PDF content)
19
Marshall P.S. Allergy and depression, a neurochemical threshold model of the relation between the illnesses // Psychol. Bull. – 1993. – Vol. 113. – P. 23-24.
(check this in PDF content)
20
McAdam W. Aspirin. // In: Cohen M. ed. Handbook of Antiplatelet Therapy. London: Martin Dunitz. – 2003. – P. 71-95.
(check this in PDF content)
21
Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis // Review and recommendations for clinical research // Acch. Neurol. – 1990. – Vol. 47. – P. 98-104.
(check this in PDF content)
22
Mosovich S.A., Boone R.T., Reichenberg A. New insights into the link between cardiovascular disease and depression // Int. J. Clin. Pract. – 2008. – Vol. 62. – P. 423-432.
(check this in PDF content)
23
Myint A.M., Mahony S., Kubera M., Kim Y.K., Kenny C., Kaim-Basta A., Steinbush H.W., Leonard B.E. Role of paroxetine in interferonalpha-induced immune and behavioural changes in male Wistar rats. // J. Psychopharmacol. – 2007. – Vol. 21. – P. 843-850.
(check this in PDF content)
24
Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter // Clin. Chem. – 1994. – Vol. 40. – P. 288-295.
(check this in PDF content)
25
Pitossi F., del Rey A., Kabiersch A., Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice // J. Neurosci. Research. – 1997. – Vol. 48. – P. 287 - 298.
(check this in PDF content)
26
Quarantini L.C., Bressan R.A., Galvao A., Batista-Neves S., Parana R., Miranda-Scippa A. Incidence of psychiatric side effects during regulated interferon-alpha retreatment in nonresponder hepatitis C virus-infected patients // Liver Int. – 2007. – Vol. 27. – P. 1098-1102.
(check this in PDF content)
27
Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., Laflamme L. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli // Proceedings of the Society for Experimental Biology and Medicine. – 2000. – Vol. 223. – P. 22-38.
(check this in PDF content)
28
Schloesser R.J., Huang J., Klein P.S., Manji H.K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder // Neuropsychopharmacol. – 2008. – Vol. 33. – P. 110 - 133.
(check this in PDF content)
29
Sheline Y.I., Bardgett M.E., Jackson J.L. Platelet serotonin markers and depressive symptomatology // Biol. Psychiatr. – 1995. – Vol. 37. – P. 442-447.
(check this in PDF content)
30
Silvermann M.N., Pearse B.D., Miller A.H. Cytokines and HPA axis regulation // In: Kronfol Z. Editor. Cytokines and Mental Health, Kluwer, Norvell, Maas. – 2003. – P. 85-122.
(check this in PDF content)
31
Smith R.S. The macrophage theory of depression // Med. Hypothesis. – 1991. – Vol. 35. – P. 298-306.
(check this in PDF content)
32
Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., Wu S.R. Cytokines and serotonin transporter in patients with major depression // Progress in Neuropsychopharmacol. and Biological Psychiatry. – 2006. – Vol. 30. – P. 899-905.
(check this in PDF content)
33
Weisse C.S. Depression and immunocompetence, a review of the literature // Psych. Bull. – 1992. – Vol. 111. – P. 475-489.
(check this in PDF content)
34
Whooley M.A., Caska C.M., Hendrickson B.E. et al. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul study // Biol. Psychiatr. – 2007. – Vol. 62. – P. 314-320.
(check this in PDF content)
35
Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression scale // Acta Psychiatr. Scand. – 1983. – Vol. 67. – P. 361-370. поступила в редакцию 17.12.2009 принята к печати 30.03.2010
(check this in PDF content)